Cart
sales@molnova.com
Dihydroxyfumaric acid hydrate
CAS No. 199926-38-0
Dihydroxyfumaric acid hydrate ( —— )
Catalog No. M19897 CAS No. 199926-38-0
Dihydroxyfumaric acid is a known generator of superoxide anions and by hydroxyl free radicals. Dihydroxyfumarate exposure can cause insulin inhibitory effects. It can spontaneously convert to hydroxypyruvate or to oxaloglycolate.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 37 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDihydroxyfumaric acid hydrate
-
NoteResearch use only not for human use.
-
Brief DescriptionDihydroxyfumaric acid is a known generator of superoxide anions and by hydroxyl free radicals. Dihydroxyfumarate exposure can cause insulin inhibitory effects. It can spontaneously convert to hydroxypyruvate or to oxaloglycolate.
-
DescriptionDihydroxyfumaric acid is a known generator of superoxide anions and by hydroxyl free radicals. Dihydroxyfumarate exposure can cause insulin inhibitory effects. It can spontaneously convert to hydroxypyruvate or to oxaloglycolate.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number199926-38-0
-
Formula Weight166.09
-
Molecular FormulaC4H6O7
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESO.OC(=O)C(\O)=C(/O)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
IRE1α kinase-IN-1
IRE1α kinase-IN-1 is a highly selective IRE1α (ERN1) inhibitor, with an IC50 of 77 nM. It displays 100-fold selectivity for IRE1α over the IRE1β isoform.
-
4-Hydroxy-3-nitrophe...
It is a small molecular drug, active to Ig heavy chain V-I region and Ig gamma-2 chain C region.
-
Arctigenin 4-O-beta-...
Arctigenin 4'-O-beta-gentiobioside is a natural product from Trachelospermum jasminoides.
